SandboxAQ Makes AQPotency Available for Drug Discovery

August 19, 2026
SandboxAQ has made AQPotency generally available on Claude through Model Context Protocol. The model ranks candidate molecules for drug discovery without requiring a solved protein structure.

SandboxAQ announced in a press release the general availability of AQPotency, a Large Quantitative Model for drug discovery that is available on Claude through Model Context Protocol. The model predicts how strongly candidate molecules are likely to act on disease targets without requiring a solved protein structure.

AQPotency ranks molecule and target pairs in seconds on ordinary computing hardware. The company said the service can cost as little as $1 per 1,000 comparisons and returns confidence information with each prediction.

The system can also start with one molecule and scan a panel of proteins to rank likely targets. SandboxAQ said the model has been used in eight customer programs with experimental validation.

AQPotency is available through Claude and SandboxAQ's website. Availability on the Marketplace from Google Cloud is planned to follow.

We hope you enjoyed this article.

Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

Healthcare & Life Sciences AI AI Brief AI Brief (X)

More from: Life Sciences

08/19
DeepCyte Launches DeeTox Atlas for AI Toxicology
08/19
Oracle Health Adds Coding and Dictation to Clinical AI Agent
08/19
Empatica Gets FDA Clearance for Parkinson's Monitoring Platform
08/19
Luma Health and PCC Add AI Communications to Pediatric EHR
08/19
Ours Privacy Raises $15M for Healthcare Marketing Data Platform

Subscribe to Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

AI Token Webinar

Market report

AI’s Time-to-Market Quagmire: Why Enterprises Struggle to Scale AI Innovation

ModelOp

The 2025 AI Governance Benchmark Report by ModelOp provides insights from 100 senior AI and data leaders across various industries, highlighting the challenges enterprises face in scaling AI initiatives. The report emphasizes the importance of AI governance and automation in overcoming fragmented systems and inconsistent practices, showcasing how early adoption correlates with faster deployment and stronger ROI.

Read more

You May Also Like